Brind.

An executive order was issued to accelerate research related to drug policy in the US.

Steady: 1 development in the last 24 hours, 1 in the last 7 days Updated 53 minutes ago

The latest in this situation

  1. Trump EO reclassifies marijuana; Evers urges pushback; Wisconsinites cross to Illinois

How it started

4 reports, 4 independent, last reported Jun 6. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

An executive order was issued to accelerate research related to drug policy in the US.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. The administration expanded its drug discount program on June 6, 2026.Sub-event
  2. Marty Makary, who was a top official leading drug policy, conducted polls on behalf of President Trump.Sub-event
  3. Executive order shifts cannabis classification from Schedule I to Schedule III.Sub-event
  4. Executive order aims to accelerate drug policy research in the US.1 source
  5. EO directs FDA to prioritize psychedelic therapies for research.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped